Pharmaceutical Name: GSK-BOL
• Investigated for treating decreased mobility and functional limitations in individuals with muscle weakness due to chronic and acute diseases.
• Aims to explore the pharmacokinetic and efficacy relationship, gathering additional safety and tolerability data.